Dirk Pamperin
Direktor/Vorstandsmitglied bei SYNTHAVERSE S.A.
Aktive Positionen von Dirk Pamperin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYNTHAVERSE S.A. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
APOGEPHA Arzneimittel GmbH
 APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Vorstandsvorsitzender | 01.01.2018 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.01.2018 |
Karriereverlauf von Dirk Pamperin
Ehemalige bekannte Positionen von Dirk Pamperin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Synthon BV
 Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | 01.01.2012 |
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | 01.01.1998 | 01.01.2005 |
Ausbildung von Dirk Pamperin
| Technische Universität Braunschweig | Undergraduate Degree |
| Universität Stuttgart | Doctorate Degree |
Statistik
International
| Deutschland | 4 |
| Polen | 2 |
| Niederlande | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNTHAVERSE S.A. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Health Services |
Synthon BV
Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Health Technology |
- Börse
- Insiders
- Dirk Pamperin
- Erfahrung
